halofuginone has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, TJ; Djuretic, IM; Koralov, SB; Pellerin, A; Rao, A; Sundrud, MS; Trivigno, C | 1 |
| Calado, DP; Feuerer, M; Keller, T; Koralov, SB; Kozhaya, AE; Lefebvre, RE; Mazitschek, R; Rao, A; Rhule-Smith, A; Sundrud, MS; Unutmaz, D; Waldner, H; Whitman, M | 1 |
2 other study(ies) available for halofuginone and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Halofuginone-induced amino acid starvation regulates Stat3-dependent Th17 effector function and reduces established autoimmune inflammation.
Topics: Amino Acids; Animals; Encephalomyelitis, Autoimmune, Experimental; Inflammation; Interleukin-23; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Knockout; Phosphorylation; Piperidines; Quinazolinones; Receptors, CCR6; Receptors, Interleukin; STAT3 Transcription Factor; Th17 Cells | 2014 |
Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response.
Topics: Activating Transcription Factor 4; Amino Acids; Animals; Autoimmunity; Cell Differentiation; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Eukaryotic Initiation Factor-2; Gene Expression; Humans; Interleukin-17; Lymphopoiesis; Mice; Mice, Inbred C57BL; Phosphorylation; Piperidines; Protein Serine-Threonine Kinases; Quinazolinones; Signal Transduction; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer | 2009 |